Brokers Issue Forecasts for Editas Medicine Q1 Earnings
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Editas Medicine in a research report issued on Monday, April 28th. HC Wainwright analyst M. Kapoor expects that the company will earn ($0.55) per share for the quarter. HC Wainwright has a “Strong-Buy” rating and […]
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Editas Medicine in a research report issued on Monday, April 28th. HC Wainwright analyst M. Kapoor expects that the company will earn ($0.55) per share for the quarter. HC Wainwright has a “Strong-Buy” rating and […]
